Firstly, there are numerous complications associated with diabetes (e.g. ocular, renal, cutaneous, and cardiovascular conditions), and the genetic architecture of each comorbidity could potentially influence our result regarding the association of MEG3 gene variations with DN. This evidence concerns the gene MEG3 and liver dysplastic nodule.